Don’t Expect to Add the Antiarrhythmic Bretylium to Crash Carts

February 2020
The revival of bretylium will raise questions about antiarrhythmics for advanced cardiovascular life support (ACLS)...

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote